While many in the world are focusing on the headline-grabbing Zika outbreak, another mosquito-borne disease has left hundreds dead in Angola. Responding to the…

The FDA approved PaxVax’s oral cholera vaccine on Friday, making it the first licensed cholera vaccine in the U.S. and the only single-dose cholera vaccine…

The meningococcal vaccine market is set for a shakeup as GlaxoSmithKline--on the heels of recent acquisitions and a launch--is expected to overtake Sanofi for…

With the Zika virus continuing its worldwide spread, a vial is heading to Hawaii for animal trials on a potential vaccine. On Tuesday, a state board approved a…

Big Pharma is approaching the current Zika outbreak cautiously with concerns about the marketability of a Zika vaccine.

Bavarian Nordic announced today positive topline results from a Phase I trial of its RSV candidate and revealed a $100 million contract to supply HHS’ BARDA…

As the quest for a Zika vaccine unfolds, Inovio Pharma continues to lead the pack. The Pennsylvania-based vaccine maker announced on Monday that its candidate…

As developers introduce new vaccines against a host of diseases, more implementation testing is required to best inform rollout decisions.

The race to advance a Zika vaccine will have a new entrant in Baltimore-based Pharos Biologicals.